Research output per year
Research output per year
- 1 - 50 out of 328 results
Search results
-
2025
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]
Bauman, J. R., Liu, G., Preeshagul, I., Liu, S. V., Melosky, B., Abrahami, D., Li, B., Thomaidou, D., Duncan, K., Krulewicz, S., Rupp, M. & Lin, J. J., Mar 2025, In: Lung Cancer. 201, p. 108441 108441.Research output: Contribution to journal › Comment/debate
-
Effective immunosurveillance of clonally expanded mammary aneuploid cells
Galluzzi, L., Manic, G. & Vitale, I., Feb 2025, In: Cellular and Molecular Immunology. 22, 2, p. 131-133 3 p.Research output: Contribution to journal › Comment/debate
-
Healing the heart, one variant at a time
Mohsin, S., Yang, X., Wang, H. & Khan, M., Mar 11 2025, In: Molecular Therapy Nucleic Acids. 36, 1, 102407.Research output: Contribution to journal › Comment/debate
Open Access -
In Brief
Dugan, M. M., Shannon, A. B., DePalo, D. K., Tsai, K. Y., Farma, J. M., Gonzalez, R. J. & Zager, J. S., Feb 2025, In: Current Problems in Surgery. 63, p. 101564 101564.Research output: Contribution to journal › Comment/debate
Open Access -
Integrating priorities at the intersection of cancer and neuroscience
Hwang, W. L., Perrault, E. N., Birbrair, A., Mattson, B. J., Gutmann, D. H., Mabbott, D. J., Cukierman, E., Repasky, E. A., Sloan, E. K., Zong, H., Demir, I. E., Saloman, J. L., Borniger, J. C., Hu, J., Dietrich, J., Breunig, J. J., Çifcibaşı, K., Ahmad Kasm, K. A., Valiente, M. & Wintermark, M. & 12 others, , Jan 13 2025, In: Cancer Cell. 43, 1, p. 1-5 5 p.Research output: Contribution to journal › Comment/debate
-
Mitochondrial succinate feeds T cell exhaustion in cancer
Galluzzi, L., Guilbaud, E. & Garg, A. D., Feb 10 2025, In: Cancer Cell. 43, 2, p. 168-170 3 p.Research output: Contribution to journal › Comment/debate
-
Serious Illness Conversations and Advance Care Planning: Can Machine-Learning or AI Really Help?
Geynisman, D. M., Feb 2025, In: JNCCN Journal of the National Comprehensive Cancer Network. 23, 2, p. 1 1 p.Research output: Contribution to journal › Comment/debate
-
T cell exhaustion: early or late in tumour progression?
Galluzzi, L., 2025, (Accepted/In press) In: Nature Reviews Immunology.Research output: Contribution to journal › Comment/debate
-
TPC2 controls MITF expression and metastasis in melanoma
Zaidi, M. R. & Soboloff, J., Jan 2025, In: Cell Calcium. 125, p. 102989 102989.Research output: Contribution to journal › Comment/debate
-
2024
Author Correction: Genetic drivers and cellular selection of female mosaic X chromosome loss
FinnGen, Estonian Biobank Research Team, Breast Cancer Association Consortium, ABCTB Investigators, CTS Consortium & Million Veteran Program, Dec 19 2024, In: Nature. 636, 8043, p. E7Research output: Contribution to journal › Comment/debate
Open Access -
Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
Li, R., Shah, P. H., Stewart, T. F., Nam, J. K., Bivalacqua, T. J., Lamm, D. L., Uchio, E. M., Geynisman, D. M., Jacob, J. M., Meeks, J. J., Dickstein, R., Pearce, S. M., Kang, S. H., Jung, S. I., Kamat, A. M., Burke, J. M., Keegan, K. A. & Steinberg, G. D., Jul 2024, In: Nature Medicine. 30, 8, p. 2372 1 p.Research output: Contribution to journal › Comment/debate
Open Access2 Scopus citations -
Correction: Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
Tuderti, G., Mastroianni, R., Proietti, F., Wu, Z., Wang, L., Franco, A., Abdollah, F., Finati, M., Ferro, M., Tozzi, M., Porpiglia, F., Checcucci, E., Bhanvadia, R., Margulis, V., Bronimann, S., Singla, N., Hakimi, K., Derweesh, I. H., Correa, A. & Helstrom, E. & 17 others, , Dec 2024, In: World Journal of Urology. 42, 1, 641.Research output: Contribution to journal › Comment/debate
Open Access -
Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014))
Wu, Z., Chen, Q., Djaladat, H., Minervini, A., Uzzo, R. G., Sundaram, C., Rha, K. H., Gonzalgo, M. L., Mehrazin, R., Mazzone, E., Marcus, J., Danno, A., Porter, J., Asghar, A., Ghali, F., Guruli, G., Douglawi, A., Cacciamani, G., Ghoreifi, A. & Simone, G. & 16 others, , May 2024, In: European Urology Focus. 10, 3, p. 502 1 p.Research output: Contribution to journal › Comment/debate
-
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]
Bauman, J. R., Liu, G., Preeshagul, I., Liu, S. V., Melosky, B., Abrahami, D., Li, B., Thomaidou, D., Duncan, K., Krulewicz, S., Rupp, M. & Lin, J. J., Nov 2024, In: Lung Cancer. 197, 108000.Research output: Contribution to journal › Comment/debate
Open Access -
Corrigendum to “Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study" [Eur Urol 84(5) (2023) 449-454]
Plimack, E. R., Powles, T., Stus, V., Gafanov, R., Nosov, D., Waddell, T., Alekseev, B., Pouliot, F., Melichar, B., Soulières, D., Borchiellini, D., McDermott, R. S., Vynnychenko, I., Chang, Y. H., Tamada, S., Atkins, M. B., Li, C., Perini, R., Molife, L. R. & Bedke, J. & 1 others, , Feb 2024, In: European Urology. 85, 2, p. e58-e59Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Editorial Comment
Omil-Lima, D. & Kutikov, A., Jan 1 2024, In: Urology Practice. 11, 1, p. 47-48 2 p.Research output: Contribution to journal › Comment/debate
-
Erratum: Correction: Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity (Cancer research communications (2024))
Shah, S. M., Demidova, E. V., Ringenbach, S., Faezov, B., Andrake, M., Gandhi, A., Mur, P., Viana-Errasti, J., Xiu, J., Swensen, J., Valle, L., Dunbrack, R. L., Hall, M. J. & Arora, S., May 31 2024, In: Cancer Research Communications. 4, 5, p. 1398 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Erratum: T-Lymphoblastic Lymphoma Cells Express High Levels of BCL2, S1P1, and ICAM1, Leading to a Blockade of Tumor Cell Intravasation (Cancer Cell (2010) 18(4) (353–366), (S1535610810003466), (10.1016/j.ccr.2010.09.009))
Feng, H., Stachura, D. L., White, R. M., Gutierrez, A., Zhang, L., Sanda, T., Jette, C. A., Testa, J. R., Neuberg, D. S., Langenau, D. M., Kutok, J. L., Zon, L. I., Traver, D., Fleming, M. D., Kanki, J. P. & Look, A. T., Jun 10 2024, In: Cancer Cell. 42, 6, p. 1130-1131 2 p.Research output: Contribution to journal › Comment/debate
Open Access -
Hope and Uncertainty in Advanced Cancers
Geynisman, D. M., Sep 1 2024, In: Journal of the National Comprehensive Cancer Network : JNCCN. 22, 7, p. 437 1 p.Research output: Contribution to journal › Comment/debate
-
Insights on Future Directions in Cancer Research from the AACR NextGen Stars
Cañadas, I., Casirati, G., Houlahan, K. E., Maxwell, K. N., Mehta, A., Parolia, A., Saulnier, O., Taylor, A. M., Thomas, C. E. & Vázquez-García, I., Sep 4 2024, In: Cancer Discovery. 14, 9, p. 1584-1589 6 p.Research output: Contribution to journal › Comment/debate
-
Progress in Cancer 2024
Geynisman, D. M., Nov 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 9, p. 581 1 p.Research output: Contribution to journal › Comment/debate
-
Publisher Correction: Patient preferences for intervention in the setting of precursor multiple myeloma (Blood Cancer Journal, (2024), 14, 1, (175), 10.1038/s41408-024-01161-0)
Marinac, C. R., Downey, K., Perry, J., Fisher-Longden, B., Rebbeck, T. R., Shah, U. A., O’Donnell, E. K., Ghobrial, I. M., Nadeem, O. & Egleston, B. L., Dec 2024, In: Blood Cancer Journal. 14, 1, 185.Research output: Contribution to journal › Comment/debate
Open Access -
Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial (Nature Medicine, (2024), 10.1038/s41591-024-03025-3)
Li, R., Shah, P. H., Stewart, T. F., Nam, J. K., Bivalacqua, T. J., Lamm, D. L., Uchio, E. M., Geynisman, D. M., Jacob, J. M., Meeks, J. J., Dickstein, R., Pearce, S. M., Kang, S. H., Jung, S. I., Kamat, A. M., Burke, J. M., Keegan, K. A. & Steinberg, G. D., Jul 2 2024, In: Nature Medicine. 30, p. 2377Research output: Contribution to journal › Comment/debate
-
Reply by Authors
Sterling, J., Simhan, J., Flynn, B. J., Rusilko, P., França, W. A., Ramirez, E. A., Angulo, J. C., Martins, F. E., Patel, H. V., Higgins, M., Swerdloff, D. & Nikolavsky, D., Apr 1 2024, In: Journal of Urology. 211, 4, p. 607 1 p.Research output: Contribution to journal › Comment/debate
-
Reply to Editorial Comment on “Factors Affecting Implant Length in Primary Inflatable Penile Prosthesis Placement”
Miller, J. A., Gross, M. S., Simhan, J., Yafi, F. A. & Barham, D. W., Nov 2024, In: Urology. 193, p. 247-248 2 p.Research output: Contribution to journal › Comment/debate
-
Sexual Rehabilitation Needs of Gay and Bisexual Men with Cancer
Wheldon, C. W., Sep 19 2024, In: JAMA Oncology. 10, 9, p. 1167-1168 2 p.Research output: Contribution to journal › Comment/debate
-
Surviving without BRCA2: MLH1 gets R-looped in to curtail genomic instability
Johnson, N., Apr 1 2024, In: Journal of Clinical Investigation. 134, 7, e179325.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
2023
ASO Author Reflections: Impact of Electromagnetic Seed Localization on Breast-Conserving Surgery
Jordan, R. M. & Bleicher, R., Jul 2023, In: Annals of Surgical Oncology. 30, 7, p. 4120-4121 2 p.Research output: Contribution to journal › Comment/debate
-
Author Correction: Polλ promotes microhomology-mediated end-joining (Nature Structural & Molecular Biology, (2023), 30, 1, (107-114), 10.1038/s41594-022-00895-4)
Chandramouly, G., Jamsen, J., Borisonnik, N., Tyagi, M., Calbert, M. L., Tredinnick, T., Ozdemir, A. Y., Kent, T., Demidova, E. V., Arora, S., Wilson, S. H. & Pomerantz, R. T., Jul 2023, In: Nature Structural and Molecular Biology. 30, 7, p. 1048 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
AUTHOR REPLY
Barham, D. W., Gross, M. S., Lentz, A. C., Simhan, J. & Yafi, F. A., Apr 2023, In: Urology. 174, p. 134 1 p.Research output: Contribution to journal › Comment/debate
-
Breast cancer diagnosis, treatment, and outcomes of patients from sex and gender minority groups
Miller, C., Bleicher, R. J. & Williams, A. D., 2023, In: Translational Cancer Research. 12, 10, p. 2458-2460 3 p.Research output: Contribution to journal › Comment/debate
Open Access -
Correction: Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 (vol 9, pg 1282, 2020): Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2 (FATP2. Cancer Discov 2020;9:1282–95)
Alicea, G., Rebecca, V., Goldman, A., Fane, M., Douglass, S. & Behera, R., Jun 2023, In: Cancer Discovery. 13, 6, p. 1498-1498 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer (British Journal of Cancer, (2023), 128, 1, (30-41), 10.1038/s41416-022-02025-9)
Curigliano, G., Shapiro, G. I., Kristeleit, R. S., Abdul Razak, A. R., Leong, S., Alsina, M., Giordano, A., Gelmon, K. A., Stringer-Reasor, E., Vaishampayan, U. N., Middleton, M., Olszanski, A. J., Rugo, H. S., Kern, K. A., Pathan, N., Perea, R., Pierce, K. J., Mutka, S. C. & Wainberg, Z. A., Jan 19 2023, In: British Journal of Cancer. 128, 2, p. 400 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Correction to: Right Information, Right Patient, Right Time: Utilizing the MyCareCompass Platform to Deliver Patient Education in the Oncology Setting (Journal of cancer education : the official journal of the American Association for Cancer Education (2023) 38 5 (1420-1428))
Fleisher, L., Kenny, C., Rusten, C., Koren, D. & Landau, Z., Dec 1 2023, In: Journal of Cancer Education. 38, 6, p. 1955 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Corrigendum to real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States [Urologic oncology: Seminars and original investigations 40 (2022) 195.e1−195.e11] (Urologic Oncology: Seminars and Original Investigations (2022) 40(5) (195.e1–195.e11), (S107814392100510X), (10.1016/j.urolonc.2021.11.014))
Geynisman, D. M., Broughton, E., Hao, Y., Zhang, Y., Le, T. & Huo, S., May 2023, In: Urologic Oncology: Seminars and Original Investigations. 41, 5, p. 259 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032))
Hernandez, N. E., Jankowski, W., Frick, R., Kelow, S. P., Lubin, J. H., Simhadri, V., Adolf-Bryfogle, J., Khare, S. D., Dunbrack, R. L., Gray, J. J. & Sauna, Z. E., Aug 2023, In: Heliyon. 9, 8, p. e17901 e17901.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Corrigendum to “Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study” [Eur. Urol. (2023)] (European Urology (2023) 84(5) (449–454), (S0302283823029019), (10.1016/j.eururo.2023.06.006))
Plimack, E. R., Powles, T., Stus, V., Gafanov, R., Nosov, D., Waddell, T., Alekseev, B., Pouliot, F., Melichar, B., Soulières, D., Borchiellini, D., McDermott, R. S., Vynnychenko, I., Chang, Y. H., Tamada, S., Atkins, M. B., Li, C., Perini, R., Rhoda Molife, L. & Bedke, J. & 1 others, , Nov 2023, In: European Urology. 84, 5, p. e123-e124Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Doubling down to make killer T cells
Kappes, D. & Wiest, D. L., Aug 2023, In: Nature Immunology. 24, 9, p. 1407-1408 2 p.Research output: Contribution to journal › Comment/debate
-
Erratum: "AAPM protocol for 40-300 kV x-ray beam dosimetry in radiotherapy and radiobiology": AAPM protocol for 40-300 kV x-ray beam dosimetry in radiotherapy and radiobiology (Medical Physics, (2001), 28, 6, (868-893), 10.1118/1.1374247)
Ma, C. M., Coffey, C. W., DeWerd, L. A., Liu, C., Nath, R., Seltzer, S. M. & Seuntjens, J. P., Jun 2023, In: Medical Physics. 50, 6, p. 3886 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Expression of Concern: α6β4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-κB-dependent resistance to apoptosis in 3D mammary acini: Erratum: Expression of Concern: α6β4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-κB-dependent resistance to apoptosis in 3D mammary acini (Journal of cell science PII: jcs261623)
Friedland, J. C., Lakins, J. N., Kazanietz, M. G., Chernoff, J., Boettiger, D. & Weaver, V. M., Oct 15 2023, In: Journal of Cell Science. 136, 20Research output: Contribution to journal › Comment/debate
Open Access -
Harnessing potent therapies with care: enfortumab vedotin plus pembrolizumab for advanced-stage urothelial carcinoma
Ghatalia, P. & Plimack, E. R., Dec 2023, In: Nature Reviews Clinical Oncology. 20, 12, p. 818-819 2 p.Research output: Contribution to journal › Comment/debate
3 Scopus citations -
HIGHLIGHTS OF THE NCCN ONCOLOGY RESEARCH PROGRAM
Treat, J., Dec 2023, In: Journal of the National Comprehensive Cancer Network : JNCCN. 21, 12, p. XXIIIResearch output: Contribution to journal › Comment/debate
Open Access -
Inflammation attenuating lncRNAs in diabetic cardiomyopathy
Mohsin, S., Wang, H. & Khan, M., Dec 12 2023, In: Molecular Therapy Nucleic Acids. 34, p. 102029 102029.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Metabolic regulation of epigenetic drug resistance
Snyder, N. W. & Meier, J. L., Oct 2023, In: Nature Chemical Biology. 19, 10, p. 1174-1175 2 p.Research output: Contribution to journal › Comment/debate
-
Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversation
Adler, F. R., Anderson, A. R. A., Bhushan, A., Bogdan, P., Bravo-Cordero, J. J., Brock, A., Chen, Y., Cukierman, E., DelGiorno, K. E., Denis, G. V., Ferrall-Fairbanks, M. C., Gartner, Z. J., Germain, R. N., Gordon, D. M., Hunter, G., Jolly, M. K., Karacosta, L. G., Mythreye, K., Katira, P. & Kulkarni, R. P. & 21 others, , Apr 19 2023, In: Cell Systems. 14, 4, p. 252-257 6 p.Research output: Contribution to journal › Comment/debate
Open Access4 Scopus citations -
Sexual and Gender Minority Invisibility in Cancer Studies: A Call for Effective Recruitment Methods to Address Cancer Disparities
Rosser, B. R. S., Weideman, B. C. D., Rider, G. N., Jatoi, A., Ecklund, A. M., Wheldon, C. W., Talley, K. M. C., Kulasingam, S., Smith, M. K., Jacobs, D. R., Mitteldorf, D., West, W., Alley, R. & Ross, M. W., Nov 20 2023, In: Journal of Clinical Oncology. 41, 33, p. 5093-5098 6 p.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Should Buprenorphine Be Considered a First-Line Opioid for the Treatment of Moderate to Severe Cancer Pain?
Chwistek, M., Sherry, D., Kinczewski, L., Silveira, M. J. & Davis, M., Nov 2023, In: Journal of Pain and Symptom Management. 66, 5, p. e638-e643Research output: Contribution to journal › Comment/debate
7 Scopus citations -
TRIMming away colon cancer: TRIM21-mediated ubiquitination as an activator of the Hippo tumor suppressor pathway
Benton, D. & Chernoff, J., Jul 20 2023, In: Cell Chemical Biology. 30, 7, p. 699-701 3 p.Research output: Contribution to journal › Comment/debate
Open Access3 Scopus citations -
What’s in a Name: An Analysis of Gender-Based Acronyms in Clinical Trials
Bukavina, L., Sindhani, M., Joshi, S. S., Plimack, E., Correa, A., Uzzo, N., Kutikov, A. & Uzzo, R., May 2023, In: Annals of Surgical Oncology. 30, 5, p. 2594-2596 3 p.Research output: Contribution to journal › Comment/debate
1 Scopus citations -
ZBP1 inflames the SARS-CoV-2-infected lung
Yin, C. & Balachandran, S., May 2023, In: Cell Research. 33, 5, p. 333-334 2 p.Research output: Contribution to journal › Comment/debate
Open Access2 Scopus citations